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Abstract
Background: The nutritional status of the mother prior to and during pregnancy plays a vital role in fetal growth
and development, and maternal undernourishment may lead to adverse perinatal outcomes including intrauterine
growth restriction (IUGR). Several macronutrient interventions had been proposed for adequate protein and energy
supplementation during pregnancy. The objective of this paper was to review the effect of balanced protein
energy supplementation during pregnancy on birth outcomes. This paper is a part of a series of reviews
undertaken for getting estimates of effectiveness of an intervention for input to Lives Saved Tool (LiST) model.
Methods: A literature search was conducted on PubMed, Cochrane Library and WHO regional data bases to
identify randomized trials (RCTs) and quasi RCTs that evaluated the impact of balanced protein energy
supplementation in pregnancy. Balanced protein energy supplementation was defined as nutritional
supplementation during pregnancy in which proteins provided less than 25% of the total energy content. Those
studies were excluded in which the main intervention was dietary advice to pregnant women for increase in
protein energy intake, high protein supplementation (i.e. supplementation in which protein provides at least 25%
of total energy content), isocaloric protein supplementation (where protein replaces an equal quantity of non-
protein energy content), or low energy diet to pregnant women who are either overweight or who exhibit high
weight gain earlier in gestation. The primary outcomes were incidence of small for gestational age (SGA) birth,
mean birth weight and neonatal mortality. Quality of evidence was evaluated according to the Child Health
Epidemiology Reference group (CHERG) adaptation of Grading of Recommendations Assessment, Development
and Evaluation (GRADE) criteria.
Results: The final number of studies included in our review was eleven comprising of both RCTs and quasi-RCTs.
Our meta-analysis indicates that providing pregnant females with balanced protein energy supplementation
resulted in a significant reduction of 31 % in the risk of giving birth to small for gestational age infants (Relative
risk (RR) =0.69, 95% Confidence interval (CI) 0.56 to 0.85). This estimate had been recommended for LiST as a proxy
for reduction in IUGR. Pooled results for mean birth weight showed that balanced protein supplemented group
gained more weight compared to control [Mean difference 59.89 g, 95 % CI 33.09-86.68]. This effect was more
pronounced in malnourished women compared to adequately nourished women. There was no statistically
significant effect of balanced protein energy supplementation on neonatal mortality (RR= 0.63, 95% CI 0.37 to 1.06).
Conclusion: Providing pregnant females with balanced protein energy supplementation leads to reduction in risk
of small for gestational age infants, especially among undernourished pregnant women. Given these findings, we
can recommend balanced protein energy supplementation as an intervention among undernourished women for
inclusion in the LiST model with a point estimate of 31% [95% CI 15% to 44%] reduction in IUGR.
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According to an estimate, approximately 30 million
newborns per year are affected with intrauterine growth
restriction (IUGR) in developing countries [1]. This rate
is six times higher than in developed countries. The
highest burden of prevalence of term low birth weight/
IUGR lies in Asia (75%), mainly South East Asia, fol-
lowed by Africa (20%) and Latin America (5%) [1].
IUGR is associated with an increase in perinatal mortal-
ity and morbidities such hypothermia, hypoglycemia,
prematurity etc [2]. Babies with restricted intrauterine
growth are more likely to have poor cognitive develop-
ment during childhood leading to neurologic impair-
ment in adulthood and also an increased risk of
cardiovascular, pulmonary and renal diseases later in life
[3,4]. It has now been shown that poor maternal nutri-
tional status at conception and inadequate maternal
nutrition during pregnancy can result in IUGR [5,6].
The main focus of maternal and fetal nutrition during
pregnancy is to achieve appropriate energy intakes (in
the form macronutrients) and ensuring that the intakes
of specific nutrients (like vitamin and minerals) are ade-
quate to meet maternal and fetal needs [7].
Several macro/micronutrient nutritional interventions
have been proposed and evaluated in accordance with
the maternal needs during pregnancy [8]. Some of the
macronutrient interventions include dietary advice to
pregnant women, balanced protein energy supplementa-
tion, high protein, isocaloric protein supplementation,
prescribing low energy diet to pregnant women who are
either overweight or who exhibit high weight gain ear-
lier in gestation [9-11]. Among these interventions,
balanced protein energy supplementation is considered
as one of the most promising macronutrient interven-
tions for prevention of adverse perinatal outcomes
including IUGR [9].
Previous reviews on maternal nutritional supplementa-
tion during pregnancy have shown that balanced protein
energy supplementation has a positive impact on both
maternal and perinatal birth outcomes [9,12]. These
reviews concluded that balanced protein energy supple-
mentation leads to a modest increase in maternal weight
gain during pregnancy and birth weight of the baby. It
was also associated with a significant reduction in small-
for-gestational-age (SGA) infants and stillbirths and with
a non-significant reduction in neonatal mortality.
The purpose of this review was to evaluate the effec-
tiveness of balanced protein energy supplementation
during pregnancy in reducing IUGR and to get a point
estimate for its inclusion in the Lives Saved Tool (LiST).
This is achieved through qualitative assessment of the
available evidence by Grading of Recommendations
Assessment, Development and Evaluation (GRADE) cri-
teria [13] and quantitative inferences based on rules
developed by the Child Health Epidemiology Reference
Group (CHERG) to collective mortality and morbidity
outcomes [14]. For more details of the review methods,
the adapted GRADE approach or the LiST model, see
the methods paper [14].
Methods
Searching
To assess the evidence of impact of maternal balanced
protein energy supplementation on pregnancy outcomes,
a literature search was conducted on PubMed, the
Cochrane library, and the World Health Organization
Regional Databases. The last date of search was Febru-
ary 28, 2010. The following search strategy was applied
for the search of articles on PubMed: (Pregnancy* OR
maternal OR “Mothers” [Mesh] OR “Pregnancy"[Mesh]
OR “Pregnant Women"[Mesh]) AND (balanced OR pro-
tein OR energy) AND (supplement*). This search strat-
egy was modified accordingly for the searches on other
databases as some of the data bases don’tt a k em e s h
terms used on PubMed. The bibliographies of available
reviews and meta-analyses were also hand searched to
look for any additional studies.
Selection (inclusion/exclusion criteria)
All randomized and quasi-randomized controlled trials
assessing impact of balanced protein energy supplemen-
tation on pregnancy outcomes were eligible for inclu-
sion, irrespective of language, geographical region or
publication status. Balanced protein energy supplemen-
tation was defined as nutritional supplementation during
pregnancy in which proteins provided less than 25% of
the total energy content [12]. Those studies were
excluded in which the main intervention was dietary
advice to pregnant women for increase in protein energy
intake, high protein supplementation (i.e. supplementa-
tion in which protein provides at least 25% of total
energy content), isocaloric protein supplementation
(where protein replaces an equal quantity of non-protein
energy content), or low energy diet to pregnant women
who are either overweight or who exhibit high weight
gain earlier in gestation. Small for gestational age was
defined as a baby whose weight was below the 10
th per-
centile for its gestational age [15], while neonatal mor-
tality was defined as death of a live born infant within
the first 28 days of life [16].
Abstraction, analyses, and summary measures
Data from all the included studies were double
abstracted onto a standardized form for each outcome
of interest. The primary outcomes of interest were small
for gestational age babies, mean birth weight and neona-
tal mortality. We abstracted key variables with regards
to the study identifiers and context (i.e. study
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study design (i.e. sequence generation, allocation con-
cealment, blinding and attrition), sample size and data
on primary outcomes. For dichotomous outcomes, the
total number of participants for each group and the
number of participants experiencing an event was
extracted. For continuous data, means with their stan-
dard deviations were abstracted. Each included study
was assessed and graded according to the CHERG adap-
tation of the GRADE criteria [13,14]. In this method of
qualitative evaluation, a randomized or a cluster rando-
mized trial was given a high score initially and the grade
was subsequently decreased or increased depending on
strengths or limitations of study. Each study was
assigned a quality grade of “high”“ moderate”“ low” or
“very low” and studies getting a score of “very low”
quality were excluded from the analysis.
For outcomes, where data were available from more
than one study, we conducted meta-analyses and
reported pooled relative risk (RR) and corresponding
95% confidence interval (CI). Assessment of statistical
heterogeneity among the pooled trials was done by
visual inspection of forest plots, by the Chi square (p-
value) and by calculating the I
2 statistic (calculated as I
2
=100% x (Q-df )/Q; where Q is Cochrane’s heterogene-
ity statistic and df is the degrees of freedom). Heteroge-
neity was taken as substantial if p-value of Chi square
was < 0.10, I
2 exceeded 50% and visual inspection of
forest plots was indicative. Reasons for heterogeneity
were explored by doing a sensitivity analysis by taking
out studies of moderate or low quality. Fixed models
were used for primary analysis. In case of cluster rando-
mized controlled trials, it was taken into account
whether the study subjects were randomized in groups
(i.e. clusters) or at individual level. Preference was given
to cluster adjusted values given in the study and if
results were not adjusted for cluster randomization,
sample size were adjusted by using an estimate of the
intra-cluster correlation co-efficient (ICC) derived from
the trial (if possible), or were inferred from similar stu-
dies [17]. Pooled estimates of the evaluated outcome
measures were calculated by the generic inverse var-
iance method. This method is a common and simple
version of the meta-analysis procedure and is so named
because the weight given to each study is chosen to be
the inverse of the variance of the effect estimate (i.e.
one over the square of its standard error) [17]. All ana-
lyses were conducted using software Review Manager
version 5 [18].
Recommendations for Lives Saved Tool (LiST) were
based on qualitative grading of the overall evidence
according to the GRADE criteria and quantitative attri-
butes according to the CHERG guidelines [14]. The
quality grade of overall evidence from all the included
studies for each outcome, was assessed on the basis of
volume and consistency of the overall evidence, the size
of the pooled effect and the strength of the statistical
evidence for an association between the intervention
and outcome [14].
Results
Trial flow
We identified 4123 titles from searches conducted in all
databases (Figure 1). After screening the titles and
abstracts, 22 studies were identified that addressed pro-
tein energy supplementation during pregnancy. Six of
these studies were excluded because the only interven-
tion in these studies was dietary advice about increase
in protein energy content [19-24]. Two studies were
excluded because they addressed high or iso-caloric pro-
tein energy supplement [25,26]. Fourteen studies
addressed balanced protein energy supplementation dur-
ing pregnancy [27-40]. Two of these studies were
excluded because both the groups received food supple-
mentation (high versus low energy) [33,34]. Another
study was excluded because of ‘very low’ quality [40].
Thus a total of eleven studies were included in this
review [27-32,35-39].
Study characteristics
Additional File 1 presents the characteristics of included
studies. Five of the included studies were from develop-
ing countries [28,30,32,36,41] and six were from devel-
oped countries [27,29,31,37-39]. In seven of the
included studies, women were undernourished and were
at risk of having a low birth weight baby
[27-30,32,35,37]. However, the method of assessment of
maternal nutrition status and risk of low birth weight
was very variable in the included studies. Additional File
2 presents the risk of bias table. Some of the studies
were at increased risk of bias for sequence generation
and allocation concealment and the grades were
adjusted accordingly.
Quantitative data synthesis
Table 1 reports the overall quality grading of the out-
c o m e sa n dr e s u l t so ft h ec o r r esponding meta-analyses
for outcomes of interest for inclusion in the LiST. Data
on small for gestational age was available from six stu-
dies [28,30-32,37,41] and the pooled results from these
studies (Figure 2) indicated that this intervention was
associated with an overall significant reduction in the
risk of small-for-gestational age babies (RR = 0.69, 95%
CI: 0.56 - 0.85). There was no heterogeneity in the
pooled estimate and all the studies were showing a
trend towards reduction. The overall quality grade of
this outcome was that of “moderate” level. On the basis
of volume, consistency and statistical significance, this
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Figure 1 Flow diagram showing identification of studies evaluating effect of balanced protein energy supplementation during pregnanancy.
Table 1 Results of pooled analysis and qualitative grading according to GRADE criteria for outcomes of interest for
inclusion in the LiST
Quality Assessment Summary of Findings
Directness No of patients Effect
No of studies Design Limitations Consistency Generalizability
to Population
of Interest
Generalizability to
Intervention of interest
Intervention Control Relative
Risk
(95% CI)
Impact of balance protein energy supplementation on small for gestational age: Quality of evidence - Moderate
6
[28,30-32,35,37]
RCTs /
Cluster
RCT/
Quasi
RCTs
Two studies were quasi
experimental trial.
Sequence generation and
allocation concealment
was not adequate in some
of the included studies.
No
heterogeneity
in the pooled
data (I
2 =0%).
p= 0.65
Studies
conducted in
both
developed and
developing
countries.
Protein content of
Supplement for
intervention group ranged
from 30 g to 44 g per
day. The protein content
provided < 25 % of total
energy content.
142 193 0.69
(0.56-
0.85)
Impact of balance protein energy supplementation on neonatal mortality: Quality of evidence - Low
3[30,37,41] RCTs/
Cluster
RCT/
Quasi
RCTs
One quasi-experimental
design. Allocation
concealment was not
adequate for one of the
included cluster
randomized controlled
trial. Large loss to follow
up in included studies.
No
heterogeneity.
(I
2 =0) p=0.81
One study
from
developed
country and
two from
developing
countries
Protein content of
Supplement for
intervention group ranged
from 30 g to 44 g per
day. The protein content
provided < 25 % of total
energy content.
23 33 0.63
(0.37-
1.06)
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tion in IUGR for the LiST model. More details about
these recommendations are presented in the discussion
section.
Three studies also reported the impact of balanced
protein energy supplementation during pregnancy on
neonatal mortality [30,37,41]. The risk of neonatal mor-
tality was lower with balanced protein energy supple-
mentation during pregnancy (RR = 0.63, 95% CI: 0.37 to
1.06); however the results did not reach statistical signif-
icance (Figure 3).
Data on mean birth weight was available from all the
eleven included studies [27-32,35-39]. Pooled results
showed that balanced protein supplemented group
gained more weight compared to control [Mean differ-
ence 59.89 g, 95 % CI 33.09-86.68]. This effect was
more pronounced in malnourished women compared to
adequately nourished women (Figure 4).
Discussion
Several reviews have concluded that the adverse birth
outcome could be directly related to poor maternal
nutritional status [9,12,42,43]. The maternal malnutri-
tion during pregnancy is commonly attributed to inade-
quate dietary intake during pregnancy or undernutrition
at the time of conception [8,33,44,45]. Intrauterine
growth restriction represents pathological inhibition of
fetal growth and failure of the fetus to attain its growth
potential [46]. IUGR has also been used as a marker to
assess complications of pregnancy with considerable
impact on long term outcomes [3]. There is however,
no standard definition of IUGR. It has been defined as a
birth weight < 2 standard deviations below the median
for gestational age, whereas others use a threshold of
3rd or 5th percentile of weight for age for the given
population [3,47]. The term small for gestational age
(SGA), usually defined as having a birth weight below
the 10th percentile of an accepted reference standard, is
often used as a proxy measure for IUGR [47]. These
two terms are however not synonymous as some SGA
infants may merely represent the lower tail of the ‘nor-
mal’ fetal growth distribution, while others who have
been affected in utero by an inadequate nutritional
milieu or other growth-inhibiting influences may never-
theless have a birth weight that is ‘appropriate’ for gesta-
tional age (AGA) [47]. Even though the terms SGA and
IUGR are not synonymous, there is correlation between
the two and the higher the SGA rate, the greater the
likelihood that SGA is a result of IUGR [15]. Consonant
with the cohort model approach first employed in the
Lancet series on maternal and child undernutrition [48],
the LiST tool employs a similar approach and uses the
effect of various maternal interventions on SGA which
is considered as a proxy measure for IUGR and an
indirect cause of mortality and morbidity in children
[14].
Our analysis indicates that there is a 31% [95% CI 15%
to 44%] reduction in the risk of delivering a SGA infant
when mothers were provided with balanced protein
energy supplementation during pregnancy. We recom-
mend this point estimate for reduction in the risk of
SGA births for use in the LiST model as effectiveness of
Study or Subgroup
Blackwell 1973
Ceesay 1997
Elwood 1981
Girija 1984
Mora 1978
Rush 1980
Total (95% CI)
Heterogeneity: Chi² = 3.31, df = 5 (P = 0.65); I² = 0%
Test for overall effect: Z = 3.56 (P = 0.0004)
Weight
4.4%
49.4%
14.8%
0.5%
7.5%
23.3%
100.0%
IV, Fixed, 95% CI
0.56 [0.21, 1.48]
0.65 [0.49, 0.87]
0.88 [0.52, 1.50]
0.09 [0.01, 1.45]
0.78 [0.37, 1.65]
0.70 [0.46, 1.07]
0.69 [0.56, 0.85]
Risk Ratio Risk Ratio
IV, Fixed, 95% CI
0.005 0.1 1 10 200
Favours experimental Favours control
Figure 2 Effect of balanced protein energy supplementation during pregnancy on risk of small-for-gestational age births.
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IUGR. All the included the studies were found to be
consistent and demonstrated little heterogeneity on
meta-analysis (Figure 2). Participants in all the included
studies for this analysis were undernourished except in
the study by Elwood et al [31]. If we exclude this study,
relative risk becomes 0.66 (95 % CI 0.53-0.82) which is
not very different from the primary pooled estimate.
This means that results for reduction in risk of SGA do
not change significantly by excluding this study and can
be generalized to undernourished women. Our results
are also comparable with that of previous reviews asses-
sing nutrition interventions during pregnancy [8,9,12].
T h eo v e r a l lq u a l i t yo fe v i d e n c ef o rt h i so u t c o m ew a so f
a ‘moderate’ level due to the quasi randomized design of
some included studies and recommended estimates
being based on studies from both developing and devel-
oped countries. A score of “moderate” means that the
reviewers are confident of the inclusion of the interven-
tion in the model and given available information are
presenting the best estimate of effectiveness. Additional
research may alter the size of the effect but is not likely
to change the inclusion in the model [14]. The direction
and magnitude of effect size for neonatal mortality was
similar to that of IUGR however the boundaries of con-
fidence interval included unity.
There was diversity in the type food used for delivery of
protein and energy among studies and included chocolate
colored liquid supplements, biscuits, milk, sesame cakes,
enriched bread and beverages etc. The control group was
either simply observed with no intervention or given
mineral and vitamin supplements only. These variations
in the supplement used are understandable keeping in
mind diversity of study sites and traditional foods used
during pregnancy in the particular study area.
Effect of balanced protein energy supplementation
seemed more pronounced in malnourished women. Our
pooled results for mean change in birth weight showed
that malnourished women benefited the most from
balanced protein energy supplementation [mean differ-
ence 74.89 g, 95 % CI 42.42-107.36] and there was no
statistically significant effect in adequately nourished
women (mean difference=27.87g, 95% CI= - 19.57,
75.31). This is however contrary to pooled results by
Kramer and Kakuma [12] who showed that there is no
overall beneficial effect of balanced protein energy sup-
plementation on birth weight. This was because they
included the study by Kardjati et al. [33] and we
excluded it. We excluded this study because both the
groups were supplemented with food (high vs. low
energy) and it was difficult to separate the effect of sup-
plementary food in the control group to establish an
association between intervention and the outcomes.
Our review has certain limitations. Given that the stu-
dies were conducted in both developed and developing
countries, it is difficult to generalize the effect of
balanced protein energy supplementation to developing
countries. However, an important thing to note is that
four [27,29,37,38] out of six studies from developed
countries included women who were undernourished as
were that of developing countries. It means that popula-
tion under study in most of the studies was similar i.e.
undernourished. However, this finding should be inter-
preted with caution as standardized maternal body mass
index cut offs were not used in these studies. The 11
included trials were of variable methodological quality;
Study or Subgroup
Ceesay 1997
Mora 1978
Rush 1980
Total (95% CI)
Heterogeneity: Chi² = 0.42, df = 2 (P = 0.81); I² = 0%
Test for overall effect: Z = 1.75 (P = 0.08)
Weight
65.2%
23.9%
10.9%
100.0%
IV, Fixed, 95% CI
0.60 [0.31, 1.15]
0.56 [0.19, 1.64]
1.02 [0.21, 5.02]
0.63 [0.37, 1.06]
Risk Ratio Risk Ratio
IV, Fixed, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Figure 3 Effect of balanced protein energy supplementation during pregnancy on risk of neonatal mortality.
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provide details of allocation concealment, addressing the
missing data etc. These may have biased the results in
favor of intervention.
In summary, given the beneficial effects of balanced
protein energy supplementation in reducing intrauterine
growth restriction, and taking into account the long
term sequel of IUGR, it is desirable that this interven-
tion should be scaled up in developing countries. Given
widespread maternal undernutrition in the developing
w o r l da n dt h ea s s o c i a t e dr i s ko fb e i n gb o r nS G A / I U G R
[49], we believe that balanced energy protein supple-
mentation can be appropriately recommended as an
intervention among malnourished pregnant women and
food insecure populations [1,3,9].
Additional material
Additional File 1: Characteristics of included studies
Additional File 2: Risk of bias among studies included studies in
this analysis
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